The Israeli Trigger for Blood Transfusions in the ICU
NCT00413816 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2006-12-20
Summary
The purpose of the study is to determine the trigger for blood transfusions in Israeli ICU patients and the possible effects of anemia on the post ICU discharge course.
Conditions
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Jonathan Cohen · Rabin Medical Center, Campus Beilinson, Petah Tikva , Israel, 49100
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Completion
- 2006-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Efficacy and Safety of Lactoferrin in Heart Failure Patients
NCT06427200 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot
NCT00126334 ·Status: COMPLETED ·Phase: PHASE4
-
Full Assessment of Clinical Transfusion Support
NCT07094646 ·Status: COMPLETED
-
Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis
NCT03062501 ·Status: UNKNOWN ·Phase: PHASE2
-
MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.
NCT00629291 ·Status: COMPLETED
-
Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia
NCT01461590 ·Status: COMPLETED ·Phase: PHASE2
-
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
NCT05153278 ·Status: COMPLETED
-
Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
NCT01039636 ·Status: COMPLETED ·Phase: PHASE1
-
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features
NCT02809274 ·Status: UNKNOWN
-
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
NCT01398644 ·Status: UNKNOWN ·Phase: PHASE3
-
Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell Anemia
NCT05081349 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
NCT05217836 ·Status: UNKNOWN
-
A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia
NCT02458625 ·Status: COMPLETED ·Phase: NA
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After Tratment
NCT04814394 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
Plasmapheresis: a Multi-modal Approach
NCT05815615 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
NCT01374919 ·Status: COMPLETED ·Phase: NA
-
Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis
NCT02854943 ·Status: COMPLETED
-
Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood Transfusion
NCT04061655 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?
NCT00502398 ·Status: UNKNOWN
-
Age of Blood in Sickle Cell Transfusion
NCT03704922 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia
NCT05921968 ·Status: UNKNOWN ·Phase: PHASE4
-
Iron Replacement in Blood Donors
NCT00327067 ·Status: COMPLETED